Nellix EndoVascular Aneurysm Sealing System: Device description, technique of implantation, and literature review.
Clinical outcome reports document that from 30% to 60% of endovascular aneurysm repair procedures are performed outside of US Food and Drug Administration-approved Instruction for Use, or "off label." Endovascular aneurysm repair performed outside of Instruction for Use has a significantly higher rate of device failure, potentially requiring device reintervention and even planned or emergent explant. The Nellix device has the potential to reduce the rate of aneurysm device failure through its novel design. The objective of this article was to introduce the Nellix EndoVascular Aneurysm Sealing System and indications for use and describe the technique of implantation. We describe various modes of endovascular aneurysm repair failure and how the Nellix system can reduce these unplanned adverse outcomes. Additional clinical applications and theoretical shortcomings of endovascular aneurysm sealing devices are detailed.
Vascular Surgery Department, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195. Electronic address: nayaracioffi@yahoo.com.
Nayara Cioffi
NC
Batagini
Vascular Surgery Department, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195.
David
D
Hardy
Vascular Surgery Department, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195.
Daniel G
DG
Clair
Vascular Surgery Department, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195.
Lee
L
Kirksey
D017544:Aortic Aneurysm, Abdominal / Q000601:surgery*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D057785:Catheters; D057867:Endoleak / Q000209:etiology / Q000601:surgery*; D057510:Endovascular Procedures / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D011474:Prosthesis Design; D015607:Stents